Trials / Terminated
TerminatedNCT04269252
CHI-907 CBD Extract and Experiences of Test Anxiety
A Randomized Controlled Test of the Effects of CHI-907 on Experiences of Test Anxiety Among College Students
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- Canopy Growth Corporation · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This is a randomized, placebo-controlled study examining the effects of CHI-907 on test anxiety specifically, and state anxiety more broadly.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | CHI-907 | CHI-907 is a high CBD extract. |
| OTHER | CHI-804 | CHI-804 is the placebo formulation. |
Timeline
- Start date
- 2020-02-03
- Primary completion
- 2021-06-01
- Completion
- 2021-06-01
- First posted
- 2020-02-13
- Last updated
- 2021-06-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04269252. Inclusion in this directory is not an endorsement.